Catatonia: Symptoms, Causes, Diagnosis, and Treatment

7 days ago

18 min read

Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy

Catatonia is a neuropsychiatric syndrome involving marked changes in movement, speech, behavior, and responsiveness. A person may become almost motionless and silent, hold an unusual position for a prolonged period, resist movement or instructions, or develop purposeless, intense motor activity. Some people show several of these signs in the same episode. Catatonia is clinically important because it can occur in psychiatric illnesses, neurological disorders, systemic medical conditions, and medication- or substance-related states. It can lead to dehydration, blood clots, serious medical complications, and, in its malignant form, life-threatening instability.

The crucial practical point is that catatonia is often treatable, but recognition and medical evaluation should be prompt. It is not established by observing that a person is quiet, "frozen," mentally overwhelmed, unusually stiff, or reluctant to talk. Diagnosis involves a cluster of observed psychomotor findings and investigation of what caused them. Current British Association for Psychopharmacology consensus guidelines identify benzodiazepines and electroconvulsive therapy (ECT) as the principal evidence-supported treatments, alongside care for the underlying illness and prevention of complications.

This article addresses the clinical informational search intent for catatonia symptoms, causes, diagnosis, differential diagnosis, acute treatment, medical safety, outcomes, and family support. Readers looking for the broader syndrome of hallucinations, delusions, and disorganized thought can consult the English Hub's psychosis overview, while its schizophrenia guide addresses one disorder in which catatonia may occur.

What Is Catatonia?

Catatonia is a recognizable pattern of abnormal psychomotor functioning. "Psychomotor" describes the interaction between mental processes and observable movement or behavior. In catatonia, that relationship may be profoundly altered: a person can appear unable to initiate ordinary actions, may maintain a posture despite obvious discomfort, or may move in repeated, unusual ways. Speech can stop, become repetitive, or mimic what another person says. These changes are often accompanied by severe disruption to eating, drinking, sleep, hygiene, or ordinary communication.

Catatonia is a syndrome: the clinical pattern itself can be identified, while clinicians separately determine its precipitating and associated condition. Modern classification therefore recognizes catatonia in relation to mood disorders, psychotic disorders, neurodevelopmental disorders, medications and substances, and nonpsychiatric medical or neurological illnesses. The World Health Organization's ICD-11 clinical descriptions and diagnostic requirements provide a distinct catatonia framework, and the 2023 international consensus guideline emphasizes that catatonia should never be assumed to mean schizophrenia.

Its exact pathophysiology is unresolved. Current models involve disruptions in systems regulating motor behavior and behavioral initiation, including GABA, glutamate, dopamine, and interconnected cortical–subcortical circuits. These proposals help organize research and clinical reasoning; no single neurotransmitter abnormality or brain scan currently diagnoses catatonia in an individual patient. The 2023 World Psychiatry update on catatonia discusses the range of presentations and diagnostic challenges.

Catatonia Symptoms: What Are the Clinical Signs?

Catatonia can appear as reduced movement, increased movement, or abnormal patterns of posture, muscle tone, imitation, and repetitive behavior. It is the combination, context, and evolution of signs that matter. A person may show marked immobility at one time and agitation at another, so descriptions based only on a "frozen" appearance overlook important presentations.

Reduced movement and response

Stupor means a marked reduction or absence of spontaneous psychomotor activity and active engagement with the environment. Mutism means little or no verbal response. Staring may involve sustained visual fixation, and withdrawal can include reduced eye contact, social engagement, food or fluid intake. Negativism refers to opposition or a lack of response to instruction or external stimulation that is not adequately explained by ordinary disagreement. These signs can make a person look asleep, detached, unwilling to cooperate, or emotionally absent even when the underlying problem is a serious clinical syndrome.

Abnormal postures, movements, and muscle responses

Posturing means maintaining an unusual, spontaneously adopted body position. Catalepsy refers to passive induction of a posture that the person then holds. Waxy flexibility describes a mild, even resistance to repositioning a limb, giving the examiner the impression that the limb can be molded and held. Other observed signs may include rigidity, grimacing, stereotypy (repetitive movements with little apparent purpose), and mannerisms (odd, exaggerated versions of otherwise purposeful actions). These are medical examination terms, not techniques for family members to test by manipulating someone else's body.

Imitation, repetition, and excitement

Echolalia is repetition of another person's speech; echopraxia is imitation of another person's movements. Catatonic excitement describes excessive, often purposeless motor activity that is not clearly driven by environmental demands. Agitation can be prominent enough that catatonia is mistaken for mania, delirium, a behavioral emergency, or another form of distress. A single repeated phrase or gesture outside this wider clinical picture is insufficient to determine catatonia.

The 12 signs in DSM-5-TR

The DSM-5-TR clinical framework uses twelve named signs: stupor, catalepsy, waxy flexibility, mutism, negativism, posturing, mannerism, stereotypy, agitation not influenced by external stimuli, grimacing, echolalia, and echopraxia. At least three signs are required within that diagnostic framework. ICD-11 similarly recognizes a syndrome of several abnormal psychomotor signs but uses its own diagnostic descriptions and categories. The two systems should not be treated as identical checklists, and the threshold is applied by a clinician in context. Diagnostic descriptions and clinical scale coverage are discussed in Francis and colleagues' review and the WHO ICD-11 publication.

Additional findings such as staring, withdrawal, and rigidity are important in bedside assessment even when they are not on DSM's twelve-sign list. In particular, persistent inability to drink, eat, swallow safely, move, or participate in medical care may create immediate health risks. Clinicians evaluate the observed signs as a whole rather than using an online symptom list to certify a diagnosis.

Types and Presentations of Catatonia

Retarded or hypokinetic catatonia

In a retarded presentation, reduced movement and responsiveness dominate. The person may remain in bed, stop speaking, stare, barely react to questions, or maintain an uncomfortable posture. The appearance can resemble severe depression, delirium, neurological illness, medication-related slowing, or reduced consciousness. Even when the person appears calm, immobility and poor fluid intake can rapidly become dangerous.

Excited or hyperkinetic catatonia

An excited presentation may include intense motor activity, impulsive or repetitive actions, pacing, agitation, and fluctuating behavior that seems disconnected from what is happening around the person. The clinical task is to identify catatonic signs while assessing medical causes and protecting the person from exhaustion, injury, dehydration, and unsafe restraint. Excitement does not automatically imply aggression or psychosis.

Malignant catatonia

Malignant catatonia is a life-threatening presentation in which catatonic symptoms occur with significant autonomic instability: fever or hyperthermia, tachycardia, marked blood-pressure fluctuations, sweating, altered consciousness, and potentially severe muscle injury or organ complications. It calls for emergency hospital assessment, intensive supportive treatment, and rapid specialist decisions about catatonia-specific therapy, including ECT. The BAP consensus guideline treats malignant catatonia as a medical emergency and discusses its overlap with neuroleptic malignant syndrome.

Periodic and recurrent catatonia

Some people have episodes that resolve and later return, sometimes with periods of much better functioning between episodes. Recurrent catatonia warrants review of the original diagnosis, medication changes and withdrawals, co-occurring psychiatric or neurological disorders, and the circumstances surrounding earlier episodes. Labels such as periodic catatonia describe a course pattern; they do not tell a clinician the cause or predict an inevitable future.

What Causes Catatonia?

Catatonia does not have one universal cause. The search for an underlying condition is fundamental to diagnosis and treatment, particularly when symptoms arise for the first time, emerge abruptly, or are accompanied by confusion, fever, seizures, neurological changes, or recent medication exposure. A person's psychiatric history matters, but a prior diagnosis must not prevent assessment for a new medical disorder. The 2023 BAP guideline and its clinical summary recommend an individualized workup of psychiatric, neurological, and systemic causes.

Mood disorders and other psychiatric conditions

Bipolar disorder, severe depressive episodes, and schizophrenia-spectrum disorders can be accompanied by catatonia. Historical teaching closely linked catatonia with schizophrenia; modern evidence and classifications recognize a broader association, with mood disorders playing an important role. Psychotic symptoms may accompany catatonia, but hallucinations and delusions are not required to recognize it. Similarly, a person with schizophrenia may experience catatonia without the movements themselves establishing the diagnosis of schizophrenia. See the Hub's schizophrenia-spectrum overview for the wider diagnostic context.

Neurological, autoimmune, infectious, and metabolic causes

Medical causes include autoimmune encephalitis—especially anti-NMDA receptor encephalitis—epileptic and postictal states, central nervous system infections, systemic inflammatory disease, metabolic or electrolyte disturbances, thyroid disease, and other neurological illnesses. The presence of fever, new seizures, headache, disorientation, abnormal vital signs, focal neurological findings, or rapid deterioration may change the urgency and direction of testing. Testing for neuronal antibodies, cerebrospinal fluid analysis, EEG, and neuroimaging are selected according to clinical findings, not ordered automatically for every person.

Autism and neurodevelopmental conditions

Catatonia can develop in people with autism or intellectual disability. Assessment may be particularly difficult because baseline patterns of speech, movement, motor stereotypy, social communication, and sensory response vary widely. A clinically important clue is a distinct change from the person's own baseline—for example, new prolonged immobility, marked slowing, altered eating, loss of previously established abilities, or episodic excitement. Family members' knowledge of ordinary function can be essential. Diagnosis still requires clinical assessment, not an assumption that longstanding autistic behavior constitutes catatonia.

Medications, substances, and withdrawal states

Certain medications and substance-related states can precipitate or complicate catatonia. Cases have been reported after exposure to dopamine-blocking medicines, following withdrawal of benzodiazepines or other treatments, and in intoxication or withdrawal contexts. Clinicians examine recent prescriptions, nonprescription products, substance exposures, dose adjustments, and abrupt discontinuations. No one should stop antipsychotics, benzodiazepines, or other prescribed treatments on the basis of this article; medication adjustments require urgent individualized medical decisions when catatonia is suspected.

Why mechanisms are still being researched

Studies of inhibitory GABA pathways, excitatory glutamate signaling, dopaminergic effects, and motor-control networks provide plausible explanations for why benzodiazepines and ECT can help. Nevertheless, diverse causes and heterogeneous presentations complicate mechanistic interpretation. The clinical diagnosis remains based on observed signs and context, while treatment selection relies on the available clinical evidence. Rogers and colleagues' consensus synthesis explicitly notes that high-quality randomized trials remain scarce.

Is Catatonia the Same as Schizophrenia, Psychosis, or Depression?

Catatonia describes an alteration in psychomotor behavior; psychosis describes a clinical syndrome that may involve hallucinations, delusions, or disorganized thought; schizophrenia is a diagnosable psychiatric disorder involving a broader longitudinal symptom pattern. These concepts can overlap, but they answer different clinical questions. A person may be catatonic without being psychotic, psychotic without being catatonic, or experience both as part of the same illness.

Depression can include pronounced slowing or near immobility, and bipolar mania can produce severe agitation. Catatonic signs may occur alongside these mood states, but clinicians evaluate whether the structured catatonia syndrome is present rather than treating every slow or agitated presentation as catatonia. The same logic applies to neurological disease and delirium. For differential context see psychosis, schizophrenia, and schizophrenia versus bipolar disorder.

"Catatonic schizophrenia" is a historical subtype rather than a current standalone subtype in DSM-5-TR and ICD-11. Modern systems allow recognition of catatonia across different diagnostic contexts. The terminology protects against the older error of presuming schizophrenia from catatonic motor symptoms alone. The WHO classification manual and 2023 update clarify the modern approach.

How Is Catatonia Diagnosed?

A clinician first recognizes the characteristic psychomotor signs and evaluates immediate safety, including vital signs, hydration, nutrition, temperature, breathing, circulation, and ability to move safely. Assessment draws on direct observation, a focused neurological and mental-status examination, a timeline obtained from the patient or collateral sources, medical and medication history, and changes from usual function. Where the presentation is severe, treatment and medical stabilization may proceed while the cause is still being investigated.

Clinical criteria and the Bush–Francis instruments

The Bush–Francis Catatonia Screening Instrument evaluates fourteen observable signs; the full Bush–Francis Catatonia Rating Scale (BFCRS) contains twenty-three items and can help assess severity and changes over time. These tools use structured definitions and help teams compare observations consistently. Their screening threshold is not the same as the DSM-5-TR three-of-twelve diagnostic rule. Clinicians use scales as aids to clinical judgment, not as substitutes for evaluation. The original Bush and colleagues' scale study reported strong interrater reliability, and Francis and colleagues discuss differences between symptom lists.

Medical and neurological workup

Tests depend on the presentation and may include blood count, electrolytes, kidney and liver function, creatine kinase when immobility or rigidity raises concern for muscle injury, glucose, thyroid studies, toxicology where indicated, infectious or inflammatory studies, electrocardiography, and clinical assessment of hydration and nutritional status. EEG may be needed if seizures or nonconvulsive status epilepticus are possible. Brain imaging, lumbar puncture, autoimmune encephalitis testing, and related investigations are considered when neurological or medical evidence warrants them. A normal individual test does not settle the diagnosis.

The lorazepam challenge

A monitored lorazepam challenge is sometimes used by clinicians when catatonia is suspected. Observable improvement in psychomotor signs after a supervised dose can support the diagnosis and guide treatment. A response is supportive rather than fully specific; lack of an immediate response does not by itself exclude catatonia. Administration route, dosing, cardiorespiratory monitoring, concurrent sedating drugs, age, and other medical issues require professional judgment. The BAP guideline describes standardized pre- and post-treatment examination and cautions against treating the challenge as a perfect diagnostic test.

Why laboratory tests cannot diagnose catatonia by themselves

There is no validated blood biomarker, genetic result, EEG pattern, or imaging finding that independently proves catatonia. Laboratory and physiological tests mainly identify complications and contributing diseases, while observation and diagnostic criteria establish the syndrome. This also means that a family video, a checklist score, or an isolated episode of mutism cannot replace medical assessment.

Conditions That Can Resemble Catatonia

Several syndromes can involve reduced movement, abnormal postures, speech loss, or agitation. Some are emergencies requiring different treatment. Clinicians often assess these possibilities in parallel, especially when symptoms began suddenly or the patient has fever, impaired consciousness, neurological signs, or medication exposure.

Delirium and encephalopathy

Delirium involves acute disturbance in attention and awareness with fluctuating course, frequently due to medical illness, medication effects, or metabolic disturbance. Catatonic signs and delirium can coexist, although diagnostic classification imposes certain distinctions. The overlap matters because treatment approaches can differ and some usual approaches to agitation may complicate catatonia. Careful assessment of attention, consciousness, physiology, and the evolving pattern is essential.

Nonconvulsive status epilepticus, stroke, and other neurological emergencies

A seizure state without obvious convulsions may involve unresponsiveness and abnormal behavior; EEG helps assess this possibility. Stroke and other structural neurological lesions can produce severe impairment of movement or speech, and acute focal neurological signs require urgent evaluation. Locked-in syndrome, akinetic mutism, and severe movement disorders require specialist neurological assessment. Apparent lack of speech should never be presumed voluntary.

Medication reactions and neuroleptic malignant syndrome

Neuroleptic malignant syndrome (NMS) is an acute, potentially fatal adverse reaction often associated with dopamine receptor blockade, classically featuring rigidity, fever, autonomic instability, and altered mental status. Malignant catatonia and NMS can look similar and may share mechanisms or precipitating factors. A history of recent antipsychotic exposure, medication changes, and clinical timing is crucial, although it does not resolve every case. Both presentations warrant emergency care. The BAP review of NMS and malignant catatonia explains the overlap and implications for treatment.

When Is Catatonia a Medical Emergency?

New or suspected catatonia deserves prompt medical evaluation. Seek emergency services immediately when a person becomes unresponsive, cannot drink or eat, cannot swallow safely, develops fever or marked rigidity, has seizures, displays severe confusion, develops dangerously abnormal movements, or shows signs of dehydration, breathing difficulty, chest pain, or rapidly changing heart rate or blood pressure. The medical team needs to assess both the syndrome and potential causes such as encephalitis, seizures, medication reactions, and severe metabolic disturbance.

Emergency risks can include fluid depletion, malnutrition, aspiration, deep vein thrombosis and pulmonary embolism, pressure injuries, urinary retention, infection, rhabdomyolysis, and problems caused by prolonged immobility. Unusual behavior should not distract from basic medical checks. Severe agitation or apparent immobility can require urgent hospitalization, sometimes with coordinated emergency medicine, psychiatry, neurology, and intensive-care input. The consensus management guideline discusses supportive care and prevention of these complications.

If a person appears catatonic at home, speak calmly, reduce unnecessary stimulation, and arrange urgent professional assessment. Do not force-feed or give drinks to someone who cannot swallow safely, forcibly move their limbs to "test" rigidity, administer someone else's sedating medication, or delay care while trying an online diagnostic test. If there is an immediate risk to life or safety, call the local emergency number.

How Is Catatonia Treated?

Effective care combines treatment of the catatonic syndrome, identification and management of the underlying condition, and medical prevention of complications. The main evidence-supported interventions are benzodiazepines—particularly lorazepam—and ECT. Treatment choice depends on severity, medical stability, likely cause, prior response, availability, and risks. Early recognition and early treatment can be important because prolonged immobility and complications worsen the clinical situation. Rogers et al. (2023) provides the most detailed modern consensus framework.

Lorazepam and other benzodiazepines

Lorazepam is widely used because many patients improve in observable motor and behavioral signs, sometimes rapidly. Clinicians may use it as part of a diagnostic challenge and then as scheduled treatment with adjustment guided by response and tolerability. Benzodiazepines can cause sedation, respiratory suppression in vulnerable patients or when combined with other sedatives, falls, and other adverse effects; ongoing care also considers dependence and withdrawal risks. These risks are evaluated against the substantial harms of untreated catatonia. Medication decisions, dose escalation, route, and tapering belong to clinicians, with careful observation and shared decision-making whenever the person can participate.

A 2026 systematic review and meta-analysis by Bot and colleagues included 53 studies, mostly small observational series or cohorts, and reported overall response in 77% of cases and remission in 55%. These are pooled results from heterogeneous nonrandomized evidence and should not be read as an individual's probability of response. The investigators did not find a clear dose–response relationship, and optimal dosing remains uncertain. This newer synthesis supports the established clinical role of benzodiazepines while making the quality and limits of the evidence visible.

Electroconvulsive therapy (ECT)

ECT is a major treatment for severe catatonia, catatonia that fails to respond adequately to benzodiazepines, and malignant presentations that require urgent intervention. Under general anesthesia and medical monitoring, a controlled electrical stimulus induces a brief therapeutic seizure. It is delivered by a trained specialist team and is accompanied by assessment of anesthetic, cardiac, cognitive, and other individual risks. The available literature and clinical consensus support its effectiveness, but protocol comparisons and high-quality randomized evidence specifically for catatonia remain limited. The BAP recommendations support ECT as a key treatment in appropriate cases.

ECT can be misunderstood because of how it is portrayed in fiction. Contemporary clinical ECT is a regulated medical procedure performed with anesthesia, muscle relaxation, and physiological monitoring. Temporary confusion, headache, and memory effects are potential adverse outcomes and should be explained in consent discussions. In a patient with severe autonomic instability, profound immobility, or deteriorating medical condition, the risks of not treating the syndrome can be substantial.

What about antipsychotic medication?

Antipsychotics may be indicated for a co-occurring psychotic disorder, but they are not the routine first-line treatment of catatonia itself. Dopamine-blocking drugs can sometimes worsen catatonic states or increase the risk of neuroleptic malignant syndrome, especially during acute or malignant presentations. If schizophrenia or another psychotic disorder is also present, clinicians determine when and how to address psychosis after weighing the stage of catatonia, medication history, benefit, and safety. This nuanced approach differs from general treatment guidance for schizophrenia or psychosis and is described in the BAP guideline.

Other proposed medications and neuromodulation

Specialists have described the use of other agents, including zolpidem, amantadine, memantine, and less-established approaches in selected circumstances. Evidence is comparatively limited and often comes from individual cases, small series, or uncontrolled research. These interventions may be considered when established options are unavailable, contraindicated, or insufficient, but they should not be portrayed as equivalent first-line therapies. Drug selection always depends on the suspected cause, comorbidities, interactions, and local specialist protocols.

Supportive medical treatment is part of treatment

Fluids, nutrition, monitoring for thrombosis, skin care, prevention of aspiration, assessment for infection, and safe mobilization matter alongside syndrome-directed therapy. Severe immobility can require hospital-based multidisciplinary care, and a person who cannot participate in decisions may require appropriate legal and clinical safeguards. Once symptoms improve, teams address the underlying condition, functional restoration, sleep, nutrition, medical follow-up, and appropriate rehabilitation or psychiatric support.

How Long Does Catatonia Last, and What Is Recovery Like?

Catatonia can improve rapidly after targeted treatment, but the duration varies substantially with cause, episode severity, complications, time to recognition, and response to therapy. Some episodes resolve in days; others need a longer course, repeated treatment, or a coordinated plan for recurrent symptoms. It is inappropriate to infer a fixed duration from a generic chart or from one person's story. Rapid symptom improvement also does not guarantee that the underlying illness has resolved.

Recovery can involve renewed speech, movement, eating, and interaction, followed by treatment of any remaining depressive, psychotic, neurological, or medical symptoms. Physical deconditioning and distress from a serious episode may need follow-up. People and families may benefit from a clear written summary of the observed catatonic signs, potential triggers, effective treatments, medical complications, and a plan for urgent assessment if similar changes recur.

Catatonia in Children, Autistic People, and Older Adults

Catatonia occurs across the lifespan. Children and adolescents can show new movement slowing, unusual posturing, changes in self-care, refusal or inability to eat or drink, and reduced engagement. Clinicians must compare symptoms with developmental level and usual functioning, and distinguish catatonia from baseline stereotypies or communication differences. In autism, new regression or major changes from personal baseline may be more informative than a single behavioral sign. Specialist workup for medical and neurological conditions remains important.

Older adults may have multiple possible contributing factors: medication exposure, neurological disease, systemic illness, depression, and changing cognitive function. The clinical picture can overlap with delirium, Parkinsonism, stroke, or neurocognitive disorders. Investigation and benzodiazepine tolerability must be individualized because of risks such as sedation and falls. The BAP guidelines offer specific considerations for young people, older adults, and people with autism.

What Families and Caregivers Can Do

Family members and caregivers can contribute observations that become crucial when the person cannot describe the episode. Note approximately when normal movement, speech, food and fluid intake, sleep, and daily functioning changed; identify new fever, illness, seizures, falls, or confusion; and bring a current medication list including recent additions or discontinuations. Short, factual descriptions of observable changes are more useful than speculation about motives.

During clinical evaluation, ask the team whether catatonia has been considered, what medical causes and complications need assessment, whether a standardized scale is being used, and how treatment response will be monitored. Ask how hydration, nutrition, immobility, thrombosis prevention, and consent are being managed. After acute care, request guidance on recurrence signs, follow-up appointments, and which changes require emergency reassessment.

Communicate respectfully with the person. A lack of speech or movement is not proof that someone cannot understand. Explain actions simply, allow time for response, protect privacy, and involve the person in decisions to the greatest extent possible as their condition improves. Refrain from blaming the person for mutism, immobility, stereotyped behavior, or agitation.

Common Misconceptions About Catatonia

Catatonia is not synonymous with total paralysis: movement can be profoundly reduced, unusual, repetitive, or excessive. It is not necessarily unconsciousness: outward responsiveness and subjective awareness can differ, and clinical assessment is needed. It is not necessarily schizophrenia: the syndrome appears across psychiatric and medical conditions. It is not diagnosed solely by freezing, staring, silence, or a particular social-media video. And it is not a condition for which prolonged observation at home is a safe default when symptoms are new or severe.

Catatonia also should not be understood as evidence that the person is choosing not to participate. The syndrome can interfere with the initiation and coordination of behavior in ways that make ordinary requests impossible to follow. Treating it as intentional defiance risks delaying care and increasing harm.

Frequently Asked Questions

What is the most common symptom of catatonia?

There is no single symptom that appears in every episode. Immobility, mutism, staring, posturing, negativism, and abnormal repetitive movements are commonly assessed. Different settings and rating scales identify different patterns. Clinicians rely on multiple signs and the whole presentation rather than a single defining symptom.

Can someone with catatonia hear or understand you?

Some people may retain awareness despite showing little outward response; others may have altered awareness because of the syndrome or associated illness. External silence cannot determine what a person is experiencing. Speak respectfully, explain care, and seek clinical assessment.

Can catatonia occur without schizophrenia?

Yes. Catatonia can accompany mood disorders, autism, neurological illness, autoimmune encephalitis, metabolic disturbances, medication effects, and other conditions. It should not automatically trigger a schizophrenia diagnosis. WHO ICD-11 and BAP guidance recognize the broad range of associated conditions.

Is catatonia always an emergency?

Any new suspected catatonia warrants timely clinical evaluation because its cause and medical risks are uncertain. Immediate emergency care is especially important for fever, autonomic instability, failure to drink or eat, unresponsiveness, severe rigidity or agitation, seizures, or rapid medical deterioration.

How do doctors test for catatonia?

They observe defined psychomotor signs, take a clinical history, use instruments such as the BFCRS when helpful, and investigate underlying causes with targeted examinations and tests. A supervised lorazepam challenge may support the assessment, but no stand-alone online quiz or laboratory result definitively proves or excludes catatonia.

Is catatonia curable?

Many episodes respond to treatment and significant functional recovery is possible. Whether symptoms recur depends partly on the underlying condition, care received, and individual factors. There is no reliable universal promise of permanent remission, and treatment of associated medical or psychiatric illness remains important.

Does lorazepam always work?

No. It is a widely recommended treatment, and the 2026 systematic review found substantial response across included studies, but not everyone improved and most available research was observational. ECT and treatment of the precipitating condition are important options where indicated.

What happens if catatonia is untreated?

Prolonged immobility or severe excitement can produce dehydration, malnutrition, blood clots, pressure injuries, infection, muscle injury, and, in malignant cases, potentially fatal instability. The degree of risk depends on presentation and underlying causes, making prompt assessment essential.

Can stress alone explain catatonia?

Stress may be part of a person's history, but a clinical catatonia syndrome requires assessment for psychiatric, neurological, medication-related, and medical causes. Calling symptoms "stress" without examining their severity or possible medical drivers risks missing treatable illness.

Is catatonia the same as a freeze response?

No. A brief defensive freeze response during fear and the clinical syndrome of catatonia are distinct constructs. Severe or persistent changes in movement, responsiveness, speech, and self-care require assessment according to the medical presentation rather than interpretation through ordinary stress language.

Key Clinical Takeaways

Catatonia is a treatable neuropsychiatric syndrome of altered movement, speech, posture, and responsiveness. It can present with reduced or increased motor activity, often across several psychiatric and medical contexts. Diagnosis relies on careful observation of multiple signs, structured assessment when appropriate, and investigation of causes and complications. Lorazepam and ECT are the main evidence-supported treatments, with clinical safety monitoring and individualized decisions. Early recognition, respectful care, and urgent assessment of dangerous presentations support recovery and protect life.

The English Hub's Psychosis: Symptoms, Causes, Types, and When to Seek Help explains the broader psychosis syndrome; Schizophrenia: Symptoms, Causes, Diagnosis, Treatment, and Recovery covers a disorder that can coexist with catatonia; Schizophrenia Spectrum Disorders: Types, Differences, and Clinical Diagnosis clarifies related diagnoses; and Psychosis Due to a Medical Condition: Causes and Evaluation addresses medical differential considerations for psychosis rather than catatonia itself.

Visual Hallucinations: Causes and Medical Warning Signs

Hearing Voices: Auditory Hallucinations and When to Seek Help

Cognitive Impairment in Schizophrenia: Memory, Attention, and Functioning

References

Bot, L., Schotsman, B., Oostra, E., et al. (2026). The effect of benzodiazepines on catatonia: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 154(2), 99–115. https://doi.org/10.1111/acps.70102

Bush, G., Fink, M., Petrides, G., Dowling, F., & Francis, A. (1996). Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica, 93(2), 129–136. https://doi.org/10.1111/j.1600-0447.1996.tb09814.x

Francis, A., et al. (2023). Catatonia and its varieties: An update. World Psychiatry. https://doi.org/10.1002/wps.21119

National Institute for Health and Care Excellence. (2014, updated). Psychosis and schizophrenia in adults: Prevention and management (CG178). https://www.nice.org.uk/guidance/cg178

National Institute of Mental Health. (n.d.). Schizophrenia. https://www.nimh.nih.gov/health/publications/schizophrenia

Rogers, J. P., Oldham, M. A., Fricchione, G., et al. (2023). Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 37(4), 327–369. https://doi.org/10.1177/02698811231158232

World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. https://www.who.int/publications/i/item/9789240077263

Psychological Encyclopedia